Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability

OBJECTIVE: To evaluate changes from baseline in patient-reported outcomes for measures of functioning and disability among patients with migraine treated with galcanezumab or placebo. METHODS: Patients with episodic migraine (4–14 monthly migraine headache days) were treated with either galcanezumab...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurology
Hlavní autoři: Ford, Janet H., Ayer, David W., Zhang, Qi, Carter, Jeffrey N., Leroux, Elizabeth, Skljarevski, Vladimir, Aurora, Sheena K., Tockhorn-Heidenreich, Antje, Lipton, Richard B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693431/
https://ncbi.nlm.nih.gov/pubmed/31270220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007856
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky